bispecific
- Finance
Veraxa and OmniAb to develop bispecific ADC tumour programme
Veraxa Biotech has recently announced a groundbreaking joint discovery partnership with OmniAb to develop a bispecific antibody drug conjugate (bsADC)…
Read More »
Veraxa Biotech has recently announced a groundbreaking joint discovery partnership with OmniAb to develop a bispecific antibody drug conjugate (bsADC)…
Read More »